Consortium of
Lancashire&CumbriaLMCs

We are providing support and advice to practices on a daily basis by telephone and email and will be making resources available online here for you to access.

Please contact us with any specific issues you require support with.

COVID-19: Practices being open over bank holidays

Changes to the GP contract have been made which means the April bank holiday dates (10th and 13th) are now identified as normal working days for GP practices. Please see 3a and 3b: www.legislation.gov.uk

The position for the May bank holidays will be confirmed next month.

Our LMC HR team is handling many queries relating to this. Below is guidance provided for practices and specific queries can be emailed to us via hr@nwlmcs.org

• COVID-19 Practices open over the bank holidays
• Furlough leave

Useful resources and guidance

Letter RE: medication requests – LMC, Community Pharmacy Lancashire & Community Pharmacy Cumbria

Coronavirus guidance for employers

Advice RE: patient requests for ‘rescue packs’ and inhalers

COVID-19 Patient requests for fit notes – LMC guidance for practices

Hotel accommodation for NHSE Staff: COVID-19

Coronavirus Patient Information Leaflets in 32 different languages

IMPORTANT Caring for people at highest risk during COVID-19 pandemic EMIS NHSE 28th March

Updated advice for pregnant women who are working during the coronavirus outbreak – 26th March

PPE Update from Dr Richard Vautrey – BMA GPC England – 26th March

The BMA COVID-19 webpage

• Visit the webpage
• Updated daily with clear, practical guidance on issues such as Remote Consultations and Homeworking.
• This reference directory also offers links to official information including PHE guidance for primary care www.gov.uk and NHS England guidance for primary care www.england.nhs.uk

The BMA has also published FAQs on your contract terms and conditions which will be updated regularly.

Further to this letter from BMA’s GP Committee Chair to the profession on 19th March 2020, RCGP have published guidance on workload prioritisation during COVID-19.

Important changes are coming into effect on 6 April 2020 concerning the information that employers must provide to its employees and workers. The changes will apply to all employees and workers commencing work on or after 6 April 2020, so action should be taken now to ensure that you are ready for these changes.

Find out more

Class 4 Medicines Defect Information: Memantine 10mg Film-Coated Tablets, PL 20416/0260, (EL (20)A/11)

Crescent Pharma Ltd has informed us of a discrepancy on the product packaging.

If you have any questions about the medical content in this email, contact MHRA on info@mhra.gov.uk

Class 4 Drug Alert: Crescent Pharma Ltd and Falmingo Pharma (UK) Ltd, Ibuprofen 400mg Tablets, (EL (20)A/10) updated

Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd have informed us that the Patient Information Leaflet (PIL) within their packs for the above pharmacy (P) batches is incorrect.

Please note this is an update to EL(20)A) to include updated batches that are affected for Crescent Pharma Ltd. There are two documents attached, one is the fully updated drug alert containing all impacted batches, including those identified when the drug alert was first issued. The second document contains the newly identified batches only.

If you have any questions about the medical content in this email, contact MHRA on info@mhra.gov.uk

Summary List of field safety notices (FSNs) from medical device manufacturers from 17 to 21 February 2020

If you have any questions about the medical content in this email, contact MHRA on info@mhra.gov.uk